Works matching IS 01436570 AND DT 2007 AND VI 28 AND IP 4/5
Results: 26
Editorial.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 229, doi. 10.1002/mde.1336
- By:
- Publication type:
- Article
Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 231, doi. 10.1002/mde.1338
- By:
- Publication type:
- Article
‘Branded Generics’ as a strategy to limit cannibalization of pharmaceutical markets.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 251, doi. 10.1002/mde.1339
- By:
- Publication type:
- Article
Uncertainty and choice: the challenges of pharmaceutical efficacy, safety, and cost.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 267, doi. 10.1002/mde.1340
- By:
- Publication type:
- Article
Commentary.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 285, doi. 10.1002/mde.1341
- By:
- Publication type:
- Article
The cost of US pharmaceutical price regulation: a financial simulation model of R&D decisions.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 293, doi. 10.1002/mde.1342
- By:
- Publication type:
- Article
Commentary.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 353, doi. 10.1002/mde.1345
- By:
- Publication type:
- Article
Effects of profit-reducing policies on firm survival, financial performance, and new drug introductions in the research-based pharmaceutical industry.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 329, doi. 10.1002/mde.1344
- By:
- Publication type:
- Article
Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as ‘Equipment for Your Health’.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 371, doi. 10.1002/mde.1347
- By:
- Publication type:
- Article
Mergers and acquisitions in the pharmaceutical and biotech industries.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 307, doi. 10.1002/mde.1343
- By:
- Publication type:
- Article
Entry and competition in generic biologics.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 439, doi. 10.1002/mde.1352
- By:
- Publication type:
- Article
An industrial organization perspective on the influenza vaccine shortage.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 393, doi. 10.1002/mde.1349
- By:
- Publication type:
- Article
Determinants of drug prices and expenditures.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 357, doi. 10.1002/mde.1346
- By:
- Publication type:
- Article
A primer on the economics of re-importation of prescription drugs.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 415, doi. 10.1002/mde.1348
- By:
- Publication type:
- Article
Drug and vaccine pricing and innovation: what is the story?
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 407, doi. 10.1002/mde.1351
- By:
- Publication type:
- Article
Commentary.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 437, doi. 10.1002/mde.1350
- By:
- Publication type:
- Article
Commentary.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 453, doi. 10.1002/mde.1353
- By:
- Publication type:
- Article
Product differentiation, competition and regulation of new drugs: the case of statins in four European countries.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 455, doi. 10.1002/mde.1354
- By:
- Publication type:
- Article
Benefits and costs of newer drugs: an update.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 485, doi. 10.1002/mde.1355
- By:
- Publication type:
- Article
Generic competition and market exclusivity periods in pharmaceuticals.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 491, doi. 10.1002/mde.1356
- By:
- Publication type:
- Article
Commentary.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 467, doi. 10.1002/mde.1357
- By:
- Publication type:
- Article
The role of different types of health insurance on access and utilization: comparative results on two chronic conditions (hypertension and diabetes type II without complication).
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 503, doi. 10.1002/mde.1358
- By:
- Publication type:
- Article
Rx Roulette: combatting counterfeit pharmaceuticals in developing nations.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 509, doi. 10.1002/mde.1359
- By:
- Publication type:
- Article
The cost of biopharmaceutical R&D: is biotech different?
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 469, doi. 10.1002/mde.1360
- By:
- Publication type:
- Article
The truth about the drug companies, by Marcia Angell, Random House: New York, 2004. xx +305 pp., $24.95.
- Published in:
- 2007
- By:
- Publication type:
- Book Review
New estimates of pharmaceutical research and development spending by US-based firms from 1984 to 2003.
- Published in:
- Managerial & Decision Economics, 2007, v. 28, n. 4/5, p. 481, doi. 10.1002/mde.1362
- By:
- Publication type:
- Article